Previous Article | Next Article 
Molecular and Cellular Biology, June 2000, p. 3852-3859, Vol. 20, No. 11
0270-7306/00/$04.00+0
CD8 Coreceptor Extinction in Signaled
CD4+CD8+ Thymocytes: Coordinate Roles for Both
Transcriptional and Posttranscriptional Regulatory Mechanisms in
Developing Thymocytes
Ricardo
Cibotti,
Avinash
Bhandoola,
Terry I.
Guinter,
Susan O.
Sharrow, and
Alfred
Singer*
Experimental Immunology Branch, National
Cancer Institute, National Institutes of Health, Bethesda, Maryland
20892
Received 3 February 2000/Returned for modification 3 March
2000/Accepted 15 March 2000
 |
ABSTRACT |
T-cell development in the thymus is characterized by changing
expression patterns of CD4 and CD8 coreceptor molecules and by changes
in CD4 and CD8 gene transcription. In response to T-cell receptor (TCR)
signals, thymocytes progress through developmental transitions, such as
conversion of CD4+CD8+ (double-positive [DP])
thymocytes into intermediate CD4+CD8
thymocytes, that appear to require more-rapid changes in coreceptor expression than can be accomplished by transcriptional regulation alone. Consequently, we considered the possibility that TCR stimulation of DP thymocytes not only affects coreceptor gene transcription but
also affects coreceptor RNA stability. Indeed, we found that TCR
signals in DP thymocytes rapidly destabilized preexisting CD4 and CD8
coreceptor RNAs, resulting in their rapid elimination. Destabilization
of coreceptor RNA was shown for CD8
to be dependent on target
sequences in the noncoding region of the RNA. TCR signals also
differentially affected coreceptor gene transcription in DP thymocytes,
terminating CD8
gene transcription but only transiently reducing CD4
gene transcription. Thus, posttranscriptional and transcriptional
regulatory mechanisms act coordinately in signaled DP thymocytes to
promote the rapid conversion of these cells into intermediate
CD4+CD8
thymocytes. We suggest that
destabilization of preexisting coreceptor RNAs is a mechanism by
which coreceptor expression in developing thymocytes is rapidly altered
at critical points in the differentiation of these cells.
 |
INTRODUCTION |
Precursor cell differentiation in
the thymus proceeds via an ordered sequence of developmental events
that are best characterized by changes in surface expression of the
coreceptor molecules CD4 and CD8 (15, 25). Early thymocyte
precursors are CD4
CD8
(double negative),
and those that have successfully rearranged and expressed a productive
T-cell receptor (TCR)
chain (TCR
) are signaled to rearrange
their TCR
gene locus, to become CD4
CD8lo
precursor cells, and to subsequently differentiate into
CD4+CD8+ (double-positive [DP]) thymocytes.
As a result, most DP thymocytes express assembled 
TCR complexes
on their surface (for a review, see reference 18).
However, cell surface expression of 
TCR complexes is not
sufficient to promote the further differentiation of DP thymocytes into
mature CD4+CD8
and
CD4
CD8+ single-positive (SP) T cells. Rather,
only DP thymocytes with TCRs of appropriate specificity for intrathymic
ligands are signaled to further differentiate into
CD4+CD8
and CD4
CD8+
SP T cells (2, 3, 9, 30, 35, 36). Thus, each developmental step in the thymus is characterized by changing expression patterns of
CD4 and CD8 coreceptor molecules. However, the molecular bases for
these changing coreceptor expression patterns during thymocyte development remain to be fully elucidated.
The changes in coreceptor expression that occur during thymocyte
differentiation parallel changes in coreceptor transcription (1,
6). However, transcriptional regulation of coreceptor expression
may not be the only mechanism utilized by developing thymocytes. It is
conceivable that intrathymic differentiation also involves
posttranscriptional regulatory mechanisms to effect rapid changes in
coreceptor expression patterns in response to intrathymic signals.
Indeed, we have previously demonstrated that signals transduced by
surface 
TCR complexes on CD4
CD8lo
precursor cells block their differentiation into
CD4+CD8+ thymocytes by actively destabilizing
CD4 and CD8 coreceptor RNAs (33, 34). As a result,
expression of both CD4 and CD8 coreceptors was extinguished in these
cells, despite ongoing transcription of both coreceptor genes. It is
not clear if such posttranscriptional regulatory mechanisms also
function in thymocytes beyond the DP stage of development.
Recently, we made the surprising observation that signaled DP
thymocytes initially terminated CD8 transcription to become intermediate CD4+CD8
thymocytes regardless of
their ultimate lineage fate (E. Brugnera, A. Bhandoola, R. Cibotti, Q. Yu, T. I. Guinter, Y. Yamashita, S. O. Sharrow, and A. Singer, submitted for publication). In other words, signaled DP
thymocytes initially converted into intermediate CD4+CD8
thymocytes even when they ultimately
differentiated into CD8+ SP T cells. Importantly, we think
that it is at this intermediate CD4+CD8
stage
of development that lineage determination occurs. In intermediate CD4+CD8
thymocytes, TCR-selecting signals are
assessed for their dependence on surface CD8 coreceptor engagements:
TCR signals in DP thymocytes that are dependent on CD8 coengagement
cease on conversion of DP thymocytes into intermediate
CD4+CD8
cells because of decreased surface
CD8 coreceptor expression, whereas TCR signals in DP thymocytes that
are independent of CD8 coengagements persist on conversion of the cells
into intermediate CD4+CD8
thymocytes. As a
result, lineage choice is critically affected by the rapidity with
which CD4 and CD8 coreceptor expression can be altered in signaled DP thymocytes.
The present study was undertaken to specifically examine the
possibility that posttranscriptional, as well as transcriptional, regulatory mechanisms are activated in signaled DP thymocytes so as to
rapidly alter their expression of coreceptor molecules and to promote
their conversion into intermediate CD4+CD8
cells. Unfortunately, the asynchrony and low efficiency of intrathymic development make it virtually impossible to assess the presence or
absence of posttranscriptional regulatory events in thymocytes in vivo.
In contrast, DP thymocytes can be efficiently and synchronously signaled in vitro by antibody-induced coengagement of surface TCR and
CD2 molecules (5). Such in vitro signaling of DP thymocytes induces them to convert into intermediate
CD4+CD8
cells that are indistinguishable from
in vivo-generated intermediate CD4+CD8
thymocytes. Using this in vitro system, we found that both
transcriptional and posttranscriptional regulatory mechanisms were
activated in signaled DP thymocytes to promote their rapid conversion
into intermediate CD4+CD8
cells. We suggest
that posttranscriptional regulation is an important mechanism by which
coreceptor expression is rapidly altered at critical points in
thymocyte differentiation.
 |
MATERIALS AND METHODS |
Animals.
Young adult C56BL/6 (B6) mice were obtained from
The Jackson Laboratory (Bar Harbor, Maine). Mice deficient in
expression of either major histocompatibility complex (MHC) class II
(II0) or both MHC class II and
2-microglobulin (MHC0) molecules were bred
in our own colony from animals originally provided by L. Glimcher and
M. Grusby (11). Mice bearing a constitutive CD8.1
transgene (pCD2-CD8.1
) were generously provided by E. Robey and
B. J. Fowlkes (26).
Cell preparations.
DP thymocytes were obtained from young
adult mice by panning single-cell suspensions of thymocytes on anti-CD8
(83-12-5)-coated plates (23). These purified cells were
>96% DP thymocytes as assayed by flow-cytometric analysis.
Antibodies.
Monoclonal antibodies (MAbs) with the following
specificities were used at concentrations of 5 to 10 µg/ml to coat
plates employed in the signaling cultures: TCR
(H57-597
[17]) and CD2 (RM2-5; PharMingen). MAbs with the
following specificities were used for staining: CD4 (GK1.5), CD8.2
(2.43), and CD8.1
(113.16.1).
Culture conditions.
Purified DP thymocytes were either
stimulated with plate-bound antibodies to TCR
and CD2 or cultured in
the absence of signaling antibodies for 12 to 16 h (5).
Where indicated, stimulated thymocytes were harvested, washed, replated
in medium alone, and incubated for an additional 20 h.
Cells were cultured at 37°C, in a 5% CO2 humidified
atmosphere, in complete medium supplemented with 5 × 10
5 M 2-mercaptoethanol and 10% fetal calf serum that
had been depleted of endogenous steroids by treatment with 0.5% Norit
A charcoal and 0.05% dextran. Where indicated, actinomycin D (10 µg/ml; Sigma, St. Louis, Mo.) or cycloheximide (10 µg/ml; Sigma)
was added to cultures.
Immunofluorescence analysis and flow cytometry.
Three-color
immunofluorescence analysis and flow cytometry for CD4, CD8.2
, and
CD8.1
were performed by staining cells with phycoerythrin-conjugated
anti-CD4 MAb (GK1.5), fluorescein isothiocyanate-conjugated anti-CD8.2
MAb (2.43), and biotinylated anti-CD8.1
MAb
(113.16.1), followed by Texas red-avidin (Life Technologies,
Gaithersburg, Md.), as previously described (32). Flow
cytometry and electronic cell sorting were performed on a FACStar Plus
flow cytometer. Dead cells were excluded from analysis by propidium
iodide staining and forward light scatter gating. Data on at least
5 × 104 live cells were collected and analyzed using
software designed by the division of Computer Research and Technology
at the National Institutes of Health. Two-color sorting of
CD4+CD8+ and CD4loCD8
cells was performed on thymocytes from signaling cultures that were
stained with fluorescein isothiocyanate-anti-CD8 and
phycoerythrin-anti-CD4 MAbs.
Northern blot analysis.
Total cellular RNA was prepared from
the various cell populations. Equal amounts of RNA were denatured,
subjected to electrophoresis on agarose gels, and transferred to nylon
membranes (28). Blots were hybridized with a 2.1-kb
EcoRI fragment of mouse CD4 cDNA (19), a 0.8-kb
XhoI fragment of mouse CD8
cDNA (38), a 0.7-kb HindIII fragment of mouse TCR
cDNA (provided by S. Hedrick, University of California at San Diego), and a 1.3-kb
PstI fragment of rat glyceraldehyde-6-phosphate
dehydrogenase (GAPDH) cDNA (10). Probes were labeled with
32P by the random prime method. The 18S oligonucleotide
5'-ACGGTATCTGATCGTCTTCGAACC-3' (37) was labeled
by the use of the T4 polynucleotide kinase forward labeling reaction.
Blots were exposed overnight and analyzed with a phosphorimager.
Determination of RNA stability and half-life.
DP cells
(2.5 × 107) were treated with actinomycin D (10 µg/ml; Sigma) at the beginning of the signaling culture to block new transcription and then either signaled with a combination of anti-TCR and anti-CD2 antibodies or cultured in medium alone. Aliquots of 5 × 106 cells were removed every hour for 4 h.
Cytoplasmic RNA from each time point was processed for Northern blot
analysis. Densitometric analysis was used to calculate the percentage
of specific mRNA remaining after drug treatment. The half-life
calculated from these experiments was extrapolated from the
logarithmically transformed best-fit line by linear-regression analysis.
Nuclear run-on assays.
Nuclear run-on assays were performed
as described elsewhere (4, 24). Briefly, cells (2 × 107 to 5 × 107) were swollen in 0.5 ml of
buffer solution (0.5% Nonidet P-40, 10 mM Tris, 10 mM NaCl, 3 mM
MgCl2, pH 7.4) at 4°C for 5 min, and nuclei were released
by Dounce homogenization (Kontes Glass Co., Vineland, N.J.). Nuclei
were then incubated for 30 min at 31°C in 0.3 ml of a buffer
consisting of 10% glycerol, 10 mM Tris (pH 8), 140 mM KCl, 5 mM
MgCl2, 0.1 mM MnCl2, 1 mM
S-adenosylmethionine, 0.25 mM ATP, 0.25 mM CTP, 0.25 mM GTP
and 14.5 mM 2-mercaptoethanol in the presence of 0.30 mCi of
[32P]UTP (3,000 Ci/mmol; New England Nuclear) to allow
transcript elongation. DNase I (100 U; Worthington Biochemical Corp.)
in high-salt buffer (0.5 M NaCl, 50 mM MgCl2, 2 mM
CaCl2, 10 mM Tris [pH 7.4]) was then added, and the
nuclei were incubated for an additional 5 min at 31°C, then lysed
with 1% sodium dodecyl sulfate (SDS) and 0.2 mg of proteinase K
(Boehringer) for 30 min at 42°C. Nucleic acids were extracted with a
mixture of phenol, chloroform, and isoamyl alcohol (25:24:1) and then
precipitated with ethanol. Large-molecular-size RNA was enriched by
using Ultrafree-MC filters (PLGC type; Millipore). Total and
trichloroacetic acid-precipitable activities were monitored, and
approximately 70 to 80% of the 32P activity was
incorporated into polyribonucleotides. Equal amounts (3 × 106 to 6 × 106 trichloroacetic
acid-precipitable counts per minute) of radioactively labeled RNA were
partially digested with 0.2 N NaOH at 4°C for 10 min, neutralized
with HEPES, and hybridized to nylon filters (Amersham) which contained
immobilized and denatured 2.1-kb EcoRI fragments of mouse
CD4 cDNA (0.2 µg per slot), 0.8-kb XhoI fragments of mouse
CD8
cDNA (0.2 µg per slot), 1.3-kb PstI fragments of rat GAPDH cDNA (0.2 µg per slot), and Bluescript plasmid alone (EcoRI digested; 0.2 mg per slot). Filters were hybridized
for 2 days at 65°C in a buffer containing 10 mM Tris (pH 7.4), 10 mM
EDTA, 0.2% SDS and 0.6 M NaCl. Blots were then washed two times for 45 min each with 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate) and 2× SSC-0.1% SDS at 65°C. Blots were exposed overnight
and analyzed with a phosphorimager.
 |
RESULTS |
Rapid loss of coreceptor RNAs in signaled DP thymocytes.
To
assess the molecular events occurring in signaled DP thymocytes, DP
thymocytes were isolated and stimulated by plate-bound anti-TCR and
anti-CD2 MAbs (5). To assess the effect of such signals on
RNAs encoding CD4 and CD8 coreceptors, we quantitated coreceptor RNAs
by Northern blot analysis (Fig. 1).
First, we stimulated DP thymocytes for 16 h and then physically
separated them into nonresponding cells that remained
CD4+CD8+ cells and responding cells that became
CD4loCD8
. Nonresponding DP thymocytes fail to
respond to TCR-CD2 stimulation either because they lack surface TCR or
because they are unresponsive to TCR-transduced signals (5).
Northern blot analysis revealed that unresponsive DP thymocytes
contained both CD4 and CD8
RNAs whereas responsive,
CD4loCD8
thymocytes lacked both CD4 and
CD8
RNAs (Fig. 1). To determine the rapidity with which CD4 and
CD8
RNAs disappeared in response to stimulation, we quantitated RNA
levels at various time points after stimulation (Fig.
2). After 3 h of stimulation, both
CD4 and CD8
RNA levels were reduced by 50 to 70% (Fig. 2), an
impressive reduction made even more impressive by the fact that RNAs
from both responding and nonresponding DP thymocytes were included in
the analysis because these two subpopulations cannot be distinguished after only 3 h of signaling. Moreover, the observed quantitative reductions in CD4 and CD8
RNAs were specific for coreceptor RNAs, as
the level of the RNA encoding the housekeeping enzyme GAPDH actually
increased relative to the 18S RNA level, which remained constant (Fig.
2). Thus, TCR-CD2 signals induced a rapid and selective depletion of
both CD4 and CD8
coreceptor RNAs in signaled DP thymocytes.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of TCR-CD2 stimulation on CD4 and CD8 coreceptor
RNAs in DP thymocytes. Purified DP thymocytes from IIo mice
were stimulated with either medium or TCR- and CD2-specific plate-bound
MAbs (XTCR + XCD2) for 16 h. Approximately 50% of DP
thymocytes failed to respond (either because they did not express
surface TCR complexes or because they were unable to respond to
TCR-transduced signals) and remained CD4+CD8+,
and approximately 50% responded by reducing surface expression of both
CD4 and CD8. After stimulation, nonresponding and responding DP
thymocytes were purified by electronic sorting of the cells into
CD8+ and CD8 cell populations. The sorted
CD8+ population consisted of
CD4+CD8+ cells, whereas the CD8
cell population consisted of CD4loCD8 cells.
Each cell population was assessed for CD4, CD8 , and GAPDH RNA
expression by Northern blot hybridization with the indicated probes.
Note that the group or lane numbers in the Northern blot analysis refer
to the numbered cell populations indicated in the histograms. Lane 1, RNA from the starting cell population; lane 2, RNA from signaled
thymocytes; lane 3, RNA from purified thymocytes that did not respond
during signaling culture; lane 4, RNA from purified thymocytes that did
respond during signaling culture. In the two-color histograms, CD4
expression is depicted on the x axis and CD8 expression is
depicted on the y axis.
|
|

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 2.
Rapid kinetics of coreceptor RNA loss in signaled DP
thymocytes. CD4+CD8+ thymocytes were stimulated
for 1 to 3 h at 37°C by anti-TCR and anti-CD2 [X(TCR + CD2)] plate-bound MAbs. Total RNA was analyzed by Northern blot
hybridization with the probes indicated on the right. The relative
amounts of RNA encoding the indicated proteins were quantitated by
densitometry and are expressed in arbitrary units normalized to the 18S
rRNA level. The steady-state level of 18S rRNA was unchanged by culture
under these conditions.
|
|
Destabilization of preexisting coreceptor RNAs in signaled DP
thymocytes.
We considered that this selective loss of coreceptor
RNAs in signaled DP thymocytes might have resulted from either RNA
destabilization or termination of transcription, or both. However, the
rapidity with which CD4 and CD8
RNA levels declined suggested that
coreceptor RNAs might have been destabilized in response to
stimulation. Consequently, we determined the half-lives of preexisting
CD4 and CD8
RNAs with and without TCR-CD2 stimulation in the
presence of actinomycin D, which prevents the synthesis of new RNA
molecules (Fig. 3). We found that TCR-CD2
stimulation significantly reduced the half-lives of both CD4 and CD8
coreceptor RNAs (Fig. 3, left panel). Importantly, these reductions
were specific for coreceptor RNAs, as the half-lives of RNAs encoding
other molecules, such as TCR
and GAPDH, were actually increased by
TCR-CD2 stimulation (Fig. 3, right panel). In fact, this experiment
significantly underestimated the actual reduction in coreceptor
half-lives by TCR-CD2 signals, for two reasons: (i) RNA was necessarily
obtained from the total pool of DP thymocytes even though 50% of DP
thymocytes are unresponsive to TCR and CD2 signals; and (ii)
actinomycin D inhibits all transcription, including that of RNases
which might be responsible for degrading coreceptor RNAs. We conclude
that TCR and CD2 signals specifically destabilize both CD4 and CD8 coreceptor RNAs in responding DP thymocytes.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Destabilization of CD4 and CD8 RNAs in signaled DP
thymocytes. Purified DP thymocytes from B6 mice were stimulated with
either medium or TCR- and CD2-specific MAbs (XTCR + XCD2). To
measure RNA turnover, transcription was blocked by addition of
actinomycin D at the beginning of the signaling culture. Cells were
cultured for up to 3 h, and then total RNA was analyzed by
Northern blot hybridization with CD4, CD8 , GAPDH, and TCR probes.
The intensity of hybridization signals calculated by densitometric
analysis was normalized to the 18S rRNA level (itself unchanged) and
then used to calculate the percentage of specific RNA remaining. The
half-life was derived from the logarithmically transformed best-fit
line by linear-regression analysis. Comparable results were obtained in
two independent experiments and with two different transcriptional
inhibitors (actinomycin D and DRB). Left panel: squares, CD8 ;
circles, CD4. Right panel: squares, GAPDH, circles, TCR .
|
|
If CD4 and CD8

RNAs in DP thymocytes were degraded by proteins, such
as RNases, which were synthesized in response to TCR-CD2
signals,
treatment with cycloheximide (CHX), a protein synthesis
inhibitor,
would prevent the loss of CD4 and CD8

RNAs (
22)
(Fig.
4). In fact, addition of CHX to signaled
DP thymocytes did
prevent the loss of CD4 and CD8

RNAs (Fig.
4,
lanes 1 to 4),
supporting the concept that TCR-CD2 signals destabilized
coreceptor
RNAs by inducing the synthesis of sequence-specific proteins
(such
as RNases) that led to their degradation.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Protein synthesis is required for destabilization of
coreceptor RNAs in signaled DP thymocytes. Purified DP thymocytes from
B6 (left panel) and CD8.1 -transgenic (Tg) (right panel) mice were
placed in signaling cultures for 7 h with either medium or TCR-
and CD2-specific plate-bound MAbs. Where indicated, the culture also
contained the protein synthesis inhibitor CHX (10 µg/ml). Total RNA
from harvested cells was subjected to Northern blot analysis with the
indicated probes. The number under each lane indicates the relative
amount of RNA encoding the indicated protein quantitated by
densitometry and expressed in arbitrary units normalized to the value
for 18S rRNA. The amount of 18S rRNA was unchanged by culture under
these conditions. Endogenously encoded CD8.2 mRNA and
transgene-encoded CD8.1 mRNA were of different sizes and so could be
distinguished from one another.
|
|
While such RNases remain poorly characterized, it is known that
degradation of specific mRNA molecules often is dependent
on target
sequences present in the 3' noncoding regulatory sequences
of target
mRNAs (
20). Consequently, we assessed the destabilizing
effect of TCR and CD2 signals on coreceptor RNAs that differed
in
noncoding regulatory sequences. We utilized B6 mice made transgenic
for
CD8.1

cDNA because their thymocytes contain two different
populations of CD8

-specific mRNAs that can be distinguished by
their
different lengths: (i) CD8

mRNA that is encoded by the
CD8

.1
transgene and contains CD8

structural sequences but lacks
most 5'
and 3' CD8

untranslated regulatory sequences, and (ii)
CD8

mRNA
that is encoded by endogenous CD8.2

genes and contains
both CD8

structural and CD8

regulatory sequences. We found that
stimulation
significantly reduced the level of RNAs encoding endogenous
CD4 and
CD8.2

coreceptor molecules but not the level of RNA encoding
the
CD8.1

transgenic molecule (Fig.
4, lanes 5 and 6). We also
confirmed
that CHX blocked the TCR-signaled loss of endogenously
encoded CD4 and
CD8.2

RNAs even though it had no effect on RNA
encoded by the
CD8.1

transgene (Fig.
4, lanes 6 and 8). Importantly,
the ability of
CHX to prevent destabilization of coreceptor RNAs
in signaled DP
thymocytes was not due to CHX interfering with
TCR-CD2 signal
transduction, as CHX did not interfere with upregulation
of CD5 RNA in
the same TCR-CD2-signaled cells (Table
1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
CHX blocks destabilization of coreceptor RNAs in signaled
DP thymocytes but does not interfere with TCR-CD2
signal transductiona
|
|
We conclude that (i) coreceptor RNAs are selectively destabilized in
signaled DP thymocytes; (ii) destabilization of coreceptor
RNAs is
dependent on new protein synthesis; and (iii) destabilization
of
coreceptor RNAs, at least CD8

coreceptor RNA, is dependent
on target
sequences present in the noncoding regulatory sequences
of endogenously
encoded coreceptor
RNAs.
Coreceptor transcription in signaled DP thymocytes.
Having
demonstrated that stimulation of DP thymocytes destabilizes
endogenously encoded CD4 and CD8
coreceptor transcripts, we next
considered the possibility that stimulation also affects transcription
of CD4 and CD8
coreceptor genes. To address this possibility, we
performed nuclear run-on experiments with DP thymocytes at 0, 3, and
16 h after stimulation (Fig. 5).
Note that after 16 h of stimulation, responding DP thymocytes
could be purified away from nonresponding DP thymocytes by their
decreased expression of surface CD4 and CD8, so that nuclear run-on
experiments done after 16 h of stimulation were performed on
purified populations of responding DP thymocytes that had become
CD4loCD8
cells. We found that transcription
of both CD4 and CD8
was reduced in response to TCR-CD2 signals (Fig.
5). Reductions in the levels of CD4 and CD8
transcription were
detected after only 3 h of signaling despite the fact that we
could not yet distinguish between responding and nonresponding DP
thymocytes (Fig. 5B). Importantly, we did not detect CD8
transcription at all and CD4 transcription was reduced to 25% of its
initial value in responding DP thymocytes after 16 h of signaling
(Fig. 5). Thus, TCR-CD2 stimulation of DP thymocytes clearly reduced
transcription of CD4 coreceptor genes but selectively terminated
transcription of CD8
coreceptor genes.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of TCR and CD2 stimulation on CD4 and CD8 gene
transcription in responding DP thymocytes. (A) Purified DP thymocytes
from IIo mice were stimulated for 16 h with either
medium or TCR- and CD2-specific plate-bound MAbs (XTCR + XCD2).
The responding CD4loCD8 population was
purified from the total cell pool at the end of the signaling culture
by negative selection, using three rounds of anti-CD8 panning. Nuclear
run-on assays were performed on the indicated populations. The
resulting labeled large-sized RNAs were purified and hybridized to
nylon filters supporting immobilized denatured CD4, CD8 , and GAPDH
cDNA inserts or linear Bluescript plasmid (BS) alone. Individual
signals were scanned by a densitometer, with results being corrected
for the background obtained when the Bluescript vector alone was used.
The numbers on the right represent the fractions of the corresponding
control transcription levels (presented on the left panel) and indicate
the relative amounts of transcribed RNA expressed in arbitrary units
normalized to the level of GAPDH RNA. Although the stability of RNA
encoding the housekeeping enzyme GAPDH did change during culture, we
found that the level of transcription of GAPDH RNA did not change,
allowing us to normalize CD4 and CD8 transcription levels to that of
GAPDH. The amount of transcribed RNA in unstimulated
CD4+CD8+ thymocytes was defined as 1.0 arbitrary unit. (B) Kinetic downregulation of CD4 and CD8
transcription in responding DP thymocytes. Purified DP thymocytes from
IIo mice were stimulated for 3 or 16 h with either
medium alone or TCR- and CD2-specific plate-bound MAbs. At the
indicated times, nuclear run-on assays were performed, and the
resulting labeled large-sized RNA was purified and hybridized to nylon
filters supporting immobilized denatured CD4, CD8 , and GAPDH cDNA
inserts or linear Bluescript plasmid alone. The plots represent
relative transcription rates of CD4 and CD8 RNAs versus time of
signaling. We normalized the levels of CD4 and CD8 transcription at
each time point to that of GAPDH. Note that at the 0 and 3-h time
points, nuclear run-on assays were performed on total DP thymocytes,
whereas at 16 h they were performed on responding
CD4loCD8 cells that had been separated from
nonresponding DP thymocytes by anti-CD8 panning. Because responding and
nonresponding DP thymocytes cannot be distinguished by their surface
phenotypes after 3 h of signaling, the 3-h time point necessarily
overestimates the CD4 and CD8 transcription rates in DP thymocytes
responsive to TCR-CD2 stimulation.
|
|
We then examined coreceptor transcription in signaled DP thymocytes on
withdrawal of stimulation. Although cessation of TCR-CD2
stimulation
had previously been shown to result in selective reexpression
of CD4
coreceptor RNA transcripts and phenotypic conversion of
signaled DP
thymocytes into CD4
+CD8

cells (
5),
the transcriptional consequences of signal termination
had not been
previously assessed. Consequently, we transferred
stimulated DP
thymocytes out of "signaling" cultures into "recovery"
cultures, containing only medium, and then performed nuclear run-on
assays to measure the rates of CD4 and CD8 RNA synthesis. Relative
TCR

transcription, which is known to increase in signaled DP
thymocytes (
16), was included as a positive control (Fig.
6).
We found that relative CD4
transcription increased on cessation
of TCR-CD2 stimulation but that
CD8

transcription did not resume
(Fig.
6).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Selective upregulation of CD4 transcription during
generation of CD4+CD8 T cells in recovery
culture. Purified DP thymocytes from IIo mice were
stimulated for 16 h with either medium or TCR- and CD2-specific
plate-bound MAbs. The CD4loCD8 cell
population was obtained from the total cell pool after signaling
culture with greater than 85% purity by anti-CD8 panning and
collection of the nonadherent fraction. The enriched
CD4loCD8 cell population was then placed in
recovery culture. At the indicated time points, nuclear run-on assays
were performed and the resulting labeled large-sized RNA was purified
and hybridized to nylon filters supporting immobilized denatured CD4,
CD8 , TCR, and GAPDH cDNA inserts or linear Bluescript plasmid alone.
The plots represent relative transcription rates of CD4 and CD8 RNAs
versus time of recovery. We expressed CD4 and CD8 transcription
rates relative to that of GAPDH at each time point, with 1.0 representing the relative transcription rate of CD4, CD8 , or TCR
in unstimulated DP thymocytes at each time point.
|
|
We conclude that TCR-CD2 signaling in DP thymocytes terminates CD8

gene transcription but only transiently reduces CD4 gene
transcription.
Surface expression of coreceptor proteins in signaled DP
thymocytes.
Finally, we attempted to correlate the molecular
events that we identified in signaled DP thymocytes with changes in
surface expression of CD4 and CD8 proteins. To do so, we examined DP
thymocytes from CD8
.1-transgenic mice because the transgene-encoded
CD8
.1 protein differs from the endogenously encoded CD8
.2 protein
by only a single amino acid that does not affect its protein function, but the RNAs encoding these proteins are differentially destabilized during signaling and their transcription is regulated by different promoter elements (an endogenous CD8
promoter versus a heterologous human CD2 promoter) (Fig. 7).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of TCR and CD2 signaling on surface expression of
coreceptor proteins. Purified DP thymocytes from CD8.1 -transgenic
(Tg) mice that expressed both endogenously encoded CD8.2 and
transgene-encoded CD8.1 molecules were stimulated with immobilized
anti-TCR and anti-CD2 for 16 h and then placed in recovery
cultures containing only medium. Approximately 50% of DP thymocytes
failed to respond to TCR and CD2 signals and remained
CD4+CD8+ either because they do not express
surface TCR complexes or because they are unable to respond to
TCR-transduced signals. However, approximately 50% of DP thymocytes
responded to TCR and CD2 signals by loss of endogenously encoded CD4
and CD8 .2 proteins from their cell surfaces to become
CD4 CD8 .2 . Termination of TCR-CD2
signaling was accomplished by transfer of cells into recovery cultures
that were devoid of stimulating antibodies. In recovery culture, the
responding CD4 CD8 .2 thymocytes
selectively reexpressed CD4 to become
CD4+CD8 .2 cells. Importantly, TCR and CD2
signals modulated surface expression of endogenously encoded CD4 and
CD8 .2 coreceptor molecules in DP thymocytes but did not affect
expression of transgene-encoded CD8 .1 molecules (right column).
|
|
We found that TCR-CD2 signaling reduced surface expression of both
endogenously encoded CD4 and CD8

.2 coreceptor proteins
on responding
DP thymocytes, which became CD4

CD8

.2

(Fig.
7, left panels), precisely parallel to the effect of TCR-CD2
signaling on destabilization of endogenously encoded coreceptor
RNAs
and diminished transcription of endogenously encoded coreceptor
genes.
Cessation of TCR-CD2 signaling upon transfer into recovery
culture
resulted in selective reexpression of CD4 (but not CD8

.2)
surface
protein and conversion of responding DP thymocytes into
intermediate
CD4
+CD8

.2

thymocytes (Fig.
7, left
panels). These results precisely parallel
the effects of signal
cessation on selective termination of endogenous
CD8

.2 gene
transcription. Notably, neither TCR-CD2 signaling
nor its cessation had
any effect on surface expression of transgene-encoded
CD8

.1 proteins
despite their dramatic effects on surface expression
of endogenously
encoded CD8

.2 proteins in the same cells (Fig.
7, right panels),
precisely paralleling the absence of any effect
of TCR-CD2 signals on
either the stability of transgene-encoded
CD8

.1 RNA or transcription
from the CD8

.1 transgene. We conclude
that the effects of TCR-CD2
signaling (and its cessation) on coreceptor
RNA stability and
coreceptor gene transcription are reflected
in changes in surface
expression of coreceptor proteins on signaled
DP thymocytes during
their conversion into intermediate CD4
+CD8
thymocytes.
 |
DISCUSSION |
The present study demonstrated that stimulation of immature DP
thymocytes by coengagement of TCR and CD2 has two important molecular
consequences: (i) rapid destabilization of both CD4 and CD8 coreceptor
RNAs and (ii) alterations in coreceptor gene transcription that
eventually result in selective extinction of CD8
transcription.
Posttranscriptional degradation of preexisting coreceptor RNAs was
evident in signaled DP thymocytes within 1 to 3 h of stimulation
and for CD8
was shown to be dependent on target sequences present in
the noncoding regions of coreceptor RNA molecules. Coreceptor
transcription was also affected by TCR-CD2 signaling in DP thymocytes,
with transient reduction of CD4 gene transcription but termination of
CD8
gene transcription. Thus, the present study demonstrated that
posttranscriptional as well as transcriptional regulatory mechanisms
can be signaled in DP thymocytes and that both regulatory mechanisms
function in concert to effect the rapid conversion of signaled DP
thymocytes into intermediate CD4+CD8
thymocytes.
The present study demonstrated the existence of a posttranscriptional
regulatory mechanism in developing DP thymocytes. TCR-signaled destabilization of CD4 and CD8 coreceptor RNAs has previously been
demonstrated to be the mechanism by which TCR signals arrest the
differentiation of early CD4
CD8lo precursors
into DP thymocytes (33, 34), but it has been uncertain whether posttranscriptional regulatory mechanisms also participate in
later developmental steps in the thymus. In this regard, the present
study revealed that TCR-CD2 signals destabilized both CD4 and CD8
coreceptor RNAs in DP thymocytes within 1 to 3 h. Indeed, the very
rapidity of the elimination of preexisting coreceptor RNAs in signaled
DP thymocytes is itself indicative of its physiologic relevance, as its
role in signaled DP thymocytes is to alter coreceptor expression more
rapidly than can be accomplished by transcriptional regulatory
mechanisms alone. Notably, the rapid and transitory nature of the
posttranscriptional regulatory events described in the present study
makes them difficult to identify in asynchronously signaled populations
of DP thymocytes in vivo.
To obtain synchronously stimulated populations of DP thymocytes for the
present study, we signaled DP thymocytes in vitro with immobilized
anti-TCR and anti-CD2 MAbs. We utilized both anti-TCR and anti-CD2 MAbs
because we had previously found that TCR engagement alone is not
sufficient to induce alterations in coreceptor expression in DP
thymocytes in the absence of other thymic elements (5, 16).
In contrast, coengagement of surface TCR complexes with other surface
molecules, which we have called coinducer molecules, does successfully
signal DP thymocytes to alter coreceptor expression, with CD2 being the
most potent coinducer molecule that has been identified (5).
Interestingly, CD2 and other coinducer molecules may have ligands in
the thymus that normally induce their coengagement with TCR during
intrathymic development, so that the requirements for signaling DP
thymocytes in vitro may accurately reflect the requirements for
signaling DP thymocytes in vivo. In this regard, it should be noted
that the CD4+CD8
thymocytes that are
generated in vitro are developmentally intermediate cells that can
still further differentiate into either CD4+ or
CD8+ SP T cells and so are indistinguishable from
intermediate CD4+CD8
thymocytes that are the
progeny of signaled DP thymocytes in vivo (Brugnera et al., submitted).
Posttranscriptional elimination of preexisting CD4 and CD8 coreceptor
RNAs represents a transient mechanism for rapidly terminating synthesis
of both coreceptor proteins in signaled DP thymocytes (for a review,
see reference 21). However, the actual mechanism by
which coreceptor RNAs are selectively degraded is not well understood.
It presumably involves the synthesis of sequence-specific RNases that
specifically target noncoding sequences in coreceptor RNAs in immature
DP thymocytes. Such RNases may be related to the adenosine-uridine (AU)
binding factors (20) that have been implicated in
destabilization of various lymphokine mRNAs and whose target AU
sequences are primarily present in the 3' noncoding regions of certain
mRNAs, including coreceptor RNAs.
In addition to destabilizing both CD4 and CD8 coreceptor RNAs, TCR and
CD2 signals in DP thymocytes also affected coreceptor gene
transcription, extinguishing CD8
gene transcription but only
transiently reducing CD4 gene transcription. Importantly, CD4
transcription persisted at 25% of its initial rate and increased when
signaling ceased. In contrast, CD8
transcription was terminated in
signaled DP thymocytes and did not increase upon cessation of
signaling, accounting for conversion of signaled DP thymocytes into
intermediate CD4+CD8
cells. The control
regions that regulate CD4 and CD8
gene transcription have been
intensely investigated and found to be highly complex (1, 6-8,
12-14, 27, 29, 31). Of particular interest is the existence in
the CD4 control region of a functional silencer element that appears to
be necessary for terminating CD4 gene transcription, since no similar
silencer element appears to be necessary for terminating CD8
gene
transcription (12-14). Thus, it is interesting to speculate
that the selective termination of CD8
gene transcription that occurs
in TCR-CD2-signaled DP thymocytes may reflect the fact that termination
of CD8
gene transcription, unlike termination of CD4 gene
transcription, can be accomplished without specific activation of a
silencer element.
In conclusion, the present study has documented that
posttranscriptional and transcriptional regulatory mechanisms function coordinately in signaled DP thymocytes to effect conversion of these
cells into intermediate CD4+CD8
thymocytes.
We suggest that destabilization of preexisting coreceptor RNAs may be
an important mechanism for rapidly, but transiently, altering
coreceptor expression in immature thymocytes at various stages of development.
 |
ACKNOWLEDGMENTS |
We are grateful to B. J. Fowlkes and Ellen Robey for
providing CD8
.1-transgenic mice; Remy Bosselut, Richard Hodes, and
Dinah Singer for critically reading the manuscript; Larry Granger and Tony Adams for expert flow analysis and electronic cell sorting; and
Yousuke Takahama for advice on nuclear run-on assays.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Experimental
Immunology Branch, National Cancer Institute, Building 10, Room 4B36, Bethesda, MD 20892. Phone: (301) 496-5461. Fax: (301) 496-0887. E-mail:
SingerA{at}mail.nih.gov.
Present address: Vaccinex, L.P., Rochester, N.Y.
 |
REFERENCES |
| 1.
|
Adlam, M.,
D. D. Duncan,
D. K. Ng, and G. Siu.
1997.
Positive selection induces CD4 promoter and enhancer function.
Int. Immunol.
9:877-887[Abstract/Free Full Text].
|
| 2.
|
Berg, L. J.,
A. M. Pullen,
B. Fazekas de St. Groth,
D. Mathis,
C. Benoist, and M. M. Davis.
1989.
Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand.
Cell
58:1035-1046[CrossRef][Medline].
|
| 3.
|
Bhandoola, A.,
R. Cibotti,
J. A. Punt,
L. Granger,
A. J. Adams,
S. O. Sharrow, and A. Singer.
1999.
Positive selection as a developmental progression initiated by alpha beta TCR signals that fix TCR specificity prior to lineage commitment.
Immunity
10:301-311[CrossRef][Medline].
|
| 4.
|
Chen-Kiang, S., and D. J. Lavery.
1989.
Pulse labeling of heterogeneous nuclear RNA in isolated nuclei.
Methods Enzymol.
180:82-96[Medline].
|
| 5.
|
Cibotti, R.,
J. A. Punt,
K. S. Dash,
S. O. Sharrow, and A. Singer.
1997.
Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals.
Immunity
6:245-255[CrossRef][Medline].
|
| 6.
|
Ellmeier, W.,
S. Sawada, and D. R. Littman.
1999.
The regulation of CD4 and CD8 coreceptor gene expression during T cell development.
Annu. Rev. Immunol.
17:523-554[CrossRef][Medline].
|
| 7.
|
Ellmeier, W.,
M. J. Sunshine,
K. Losos,
F. Hatam, and D. R. Littman.
1997.
An enhancer that directs lineage-specific expression of CD8 in positively selected thymocytes and mature T cells.
Immunity
7:537-547[CrossRef][Medline].
|
| 8.
|
Ellmeier, W.,
M. J. Sunshine,
K. Losos, and D. R. Littman.
1998.
Multiple developmental stage-specific enhancers regulate CD8 expression in developing thymocytes and in thymus-independent T cells.
Immunity
9:485-496[CrossRef][Medline].
|
| 9.
|
Ernst, B. B.,
C. D. Surh, and J. Sprent.
1996.
Bone marrow-derived cells fail to induce positive selection in thymus reaggregation cultures.
J. Exp. Med.
183:1235-1240[Abstract/Free Full Text].
|
| 10.
|
Fort, P.,
L. Marty,
M. Piechaczyk,
S. el Sabrouty,
C. Dani,
P. Jeanteur, and J. M. Blanchard.
1985.
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family.
Nucleic Acids Res.
13:1431-1442[Abstract/Free Full Text].
|
| 11.
|
Grusby, M. J.,
H. Auchincloss, Jr.,
R. Lee,
R. S. Johnson,
J. P. Spencer,
M. Zijlstra,
R. Jaenisch,
V. E. Papaioannou, and L. H. Glimcher.
1993.
Mice lacking major histocompatibility complex class I and class II molecules.
Proc. Natl. Acad. Sci. USA
90:3913-3917[Abstract/Free Full Text].
|
| 12.
|
Hostert, A.,
A. Garefalaki,
G. Mavria,
M. Tolaini,
K. Roderick,
T. Norton,
P. J. Mee,
V. L. Tybulewicz,
M. Coles, and D. Kioussis.
1998.
Hierarchical interactions of control elements determine CD8 gene expression in subsets of thymocytes and peripheral T cells.
Immunity
9:497-508[CrossRef][Medline].
|
| 13.
|
Hostert, A.,
M. Tolaini,
R. Festenstein,
L. McNeill,
B. Malissen,
O. Williams,
R. Zamoyska, and D. Kioussis.
1997.
A CD8 genomic fragment that directs subset-specific expression of CD8 in transgenic mice.
J. Immunol.
158:4270-4281[Abstract].
|
| 14.
|
Hostert, A.,
M. Tolaini,
K. Roderick,
N. Harker,
T. Norton, and D. Kioussis.
1997.
A region in the CD8 gene locus that directs expression to the mature CD8 T cell subset in transgenic mice.
Immunity
7:525-536[CrossRef][Medline].
|
| 15.
|
Jameson, S. C.,
K. A. Hogquist, and M. J. Bevan.
1995.
Positive selection of thymocytes.
Annu. Rev. Immunol.
13:93-126[CrossRef][Medline].
|
| 16.
|
Kearse, K. P.,
Y. Takahama,
J. A. Punt,
S. O. Sharrow, and A. Singer.
1995.
Early molecular events induced by T cell receptor (TCR) signaling in immature CD4+ CD8+ thymocytes: increased synthesis of TCR-alpha protein is an early response to TCR signaling that compensates for TCR-alpha instability, improves TCR assembly, and parallels other indicators of positive selection.
J. Exp. Med.
181:193-202[Abstract/Free Full Text].
|
| 17.
|
Kubo, R. T.,
W. Born,
J. W. Kappler,
P. Marrack, and M. Pigeon.
1989.
Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.
J. Immunol.
142:2736-2742[Abstract].
|
| 18.
|
Levelt, C. N., and K. Eichmann.
1995.
Receptors and signals in early thymic selection.
Immunity
3:667-672[CrossRef][Medline].
|
| 19.
|
Littman, D. R., and S. N. Gettner.
1987.
Unusual intron in the immunoglobulin domain of the newly isolated murine CD4 (L3T4) gene.
Nature
325:453-455[CrossRef][Medline].
|
| 20.
|
Malter, J. S.
1989.
Identification of an AUUUA-specific messenger RNA binding protein.
Science
246:664-666[Abstract/Free Full Text].
|
| 21.
|
Malter, J. S.
1998.
Posttranscriptional regulation of mRNAs important in T cell function.
Adv. Immunol.
68:1-49[Medline].
|
| 22.
|
Malter, J. S.,
J. C. Reed, and M. Kamoun.
1988.
Induction and regulation of CD2 mRNA in human lymphocytes.
J. Immunol.
140:3233-3236[Abstract].
|
| 23.
|
Nakayama, T.,
C. H. June,
T. I. Munitz,
M. Sheard,
S. A. McCarthy,
S. O. Sharrow,
L. E. Samelson, and A. Singer.
1990.
Inhibition of T cell receptor expression and function in immature CD4+ CD8+ cells by CD4.
Science
249:1558-1561[Abstract/Free Full Text].
|
| 24.
|
Nevins, J. R.
1987.
Isolation and analysis of nuclear RNA.
Methods Enzymol.
152:234-241[Medline].
|
| 25.
|
Robey, E., and B. J. Fowlkes.
1994.
Selective events in T cell development.
Annu. Rev. Immunol.
12:675-705[CrossRef][Medline].
|
| 26.
|
Robey, E. A.,
B. J. Fowlkes,
J. W. Gordon,
D. Kioussis,
H. von Boehmer,
F. Ramsdell, and R. Axel.
1991.
Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage.
Cell
64:99-107[CrossRef][Medline].
|
| 27.
|
Salmon, P.,
O. Boyer,
P. Lores,
J. Jami, and D. Klatzmann.
1996.
Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes.
J. Immunol.
156:1873-1879[Abstract].
|
| 28.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 29.
|
Sawada, S.,
J. D. Scarborough,
N. Killeen, and D. R. Littman.
1994.
A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.
Cell
77:917-929[CrossRef][Medline].
|
| 30.
|
Sha, W. C.,
C. A. Nelson,
R. D. Newberry,
D. M. Kranz,
J. H. Russell, and D. Y. Loh.
1988.
Positive and negative selection of an antigen receptor on T cells in transgenic mice.
Nature
336:73-76[CrossRef][Medline].
|
| 31.
|
Siu, G.,
A. L. Wurster,
D. D. Duncan,
T. M. Soliman, and S. M. Hedrick.
1994.
A transcriptional silencer controls the developmental expression of the CD4 gene.
EMBO J.
13:3570-3579[Medline].
|
| 32.
|
Suzuki, H.,
J. A. Punt,
L. G. Granger, and A. Singer.
1995.
Asymmetric signaling requirements for thymocyte commitment to the CD4+ versus CD8+ T cell lineages: a new perspective on thymic commitment and selection.
Immunity
2:413-425[CrossRef][Medline].
|
| 33.
|
Takahama, Y.,
E. W. Shores, and A. Singer.
1992.
Negative selection of precursor thymocytes before their differentiation into CD4+ CD8+ cells.
Science
258:653-656[Abstract/Free Full Text].
|
| 34.
|
Takahama, Y., and A. Singer.
1992.
Post-transcriptional regulation of early T cell development by T cell receptor signals.
Science
258:1456-1462[Abstract/Free Full Text].
|
| 35.
|
Takahama, Y.,
H. Suzuki,
K. S. Katz,
M. J. Grusby, and A. Singer.
1994.
Positive selection of CD4+ T cells by TCR ligation without aggregation even in the absence of MHC.
Nature
371:67-70[CrossRef][Medline].
|
| 36.
|
Teh, H. S.,
P. Kisielow,
B. Scott,
H. Kishi,
Y. Uematsu,
H. Bluthmann, and H. von Boehmer.
1988.
Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.
Nature
335:229-233[CrossRef][Medline].
|
| 37.
|
Xia, Z.,
N. Ghildyal,
K. F. Austen, and R. L. Stevens.
1996.
Post-transcriptional regulation of chymase expression in mast cells. A cytokine-dependent mechanism for controlling the expression of granule neutral proteases of hematopoietic cells.
J. Biol. Chem.
271:8747-8753[Abstract/Free Full Text].
|
| 38.
|
Zamoyska, R.,
A. C. Vollmer,
K. C. Sizer,
C. W. Liaw, and J. R. Parnes.
1985.
Two Lyt-2 polypeptides arise from a single gene by alternative splicing patterns of mRNA.
Cell
43:153-163[CrossRef][Medline].
|
Molecular and Cellular Biology, June 2000, p. 3852-3859, Vol. 20, No. 11
0270-7306/00/$04.00+0
This article has been cited by other articles:
-
Aliahmad, P., Kaye, J.
(2008). Development of all CD4 T lineages requires nuclear factor TOX. JEM
205: 245-256
[Abstract]
[Full Text]
-
Delaire, S., Huang, Y. H., Chan, S. W., Robey, E. A.
(2004). Dynamic Repositioning of CD4 and CD8 Genes during T Cell Development. JEM
200: 1427-1435
[Abstract]
[Full Text]
-
Merkenschlager, M., Amoils, S., Roldan, E., Rahemtulla, A., O'Connor, E., Fisher, A. G., Brown, K. E.
(2004). Centromeric Repositioning of Coreceptor Loci Predicts Their Stable Silencing and the CD4/CD8 Lineage Choice. JEM
200: 1437-1444
[Abstract]
[Full Text]
-
Bosselut, R., Guinter, T. I., Sharrow, S. O., Singer, A.
(2003). Unraveling a Revealing Paradox: Why Major Histocompatibility Complex I-signaled Thymocytes "Paradoxically" Appear as CD4+8lo Transitional Cells During Positive Selection of CD8+ T Cells. JEM
197: 1709-1719
[Abstract]
[Full Text]